ORCID as entered in ROS

Select Publications
2014, 'Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2015.08.018
,2014, 'Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia', Drug and Alcohol Dependence, 144, pp. 274 - 278, http://dx.doi.org/10.1016/j.drugalcdep.2014.08.018
,2014, 'What’s the cost of finding the right fit? The cost of conducting NSP business in a range of modalities', Contemporary Drug Problems, 41, pp. 41 - 56, http://dx.doi.org/10.1177/009145091404100103
,2014, 'A piece of the jigsaw of primary care: Health professional perceptions of an integrated care model of hepatitis C management in the community', Journal of Primary Health Care, 6, pp. 129 - 134, http://dx.doi.org/10.1071/hc14129
,2014, 'Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: Insights from the ETHOS study', Journal of Viral Hepatitis, 21, pp. 560 - 567, http://dx.doi.org/10.1111/jvh.12183
,2014, ''Not just Methadone Tracy': Transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings', Addiction, 109, pp. 452 - 459, http://dx.doi.org/10.1111/add.12392
,2014, ''We are people too': Consumer participation and the potential transformation of therapeutic relations within drug treatment', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2014.05.002
,2014, 'How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting', International Journal of Drug Policy, 25, pp. 865 - 870, http://dx.doi.org/10.1016/j.drugpo.2014.01.011
,2013, 'Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia', Drug and Alcohol Dependence, 133, pp. 529 - 534, http://dx.doi.org/10.1016/j.drugalcdep.2013.07.023
,2013, 'Health literacy in relation to cancer: Addressing the silence about and absence of cancer discussion among Aboriginal people, communities and health services', Health and Social Care in the Community, 21, pp. 655 - 664, http://dx.doi.org/10.1111/hsc.12054
,2013, 'NEW INSIGHTS INTO HEPATITIS C TRANSMISSION', DRUG AND ALCOHOL REVIEW, 32, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Assessment and treatment of hepatitis c virus infection among people who inject drugs in the opioid substitution setting: ETHOS study', Clinical Infectious Diseases, 57, pp. S62 - S69, http://dx.doi.org/10.1093/cid/cit305
,2013, 'Understanding barriers to hepatitis c virus care and stigmatization from a social perspective', Clinical Infectious Diseases, 57, pp. S51 - S55, http://dx.doi.org/10.1093/cid/cit263
,2013, '"I can't do this, it's too much": Building social inclusion in cancer diagnosis and treatment experiences of Aboriginal people, their carers and health workers', International Journal of Public Health
,2013, 'At the intersection of marginalised identities: Lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion', Health and Social Care in the Community, 21, pp. 402 - 410, http://dx.doi.org/10.1111/hsc.12026
,2013, 'Authenticity and diversity: Enhancing Australian hepatitis C prevention messages', Contemporary Drug Problems, 40, pp. 505 - 529
,2013, 'Examining structural violence in opioid pharmacotherapy treatment in Australia: Sweating the "small stuff" in a liberal paradise', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2013.04.010
,2013, 'Hepatitis C prevention needs to be grounded in social relationships', Drugs - Education Prevention and Policy, http://dx.doi.org/10.3109/09687637.2013.776517
,2013, 'Knowledge and attitudes towards hepatitis C and injecting drug use among mental health support workers of a community managed organisation', Australian Health Review
,2013, 'Makes you wanna do treatment: Benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand', Health and Social Care in the Community, 21, pp. 216 - 223, http://dx.doi.org/10.1111/hsc.12009
,2013, 'Mental health support workers' attitudes towards hepatitis C and injecting drug use: Barriers to recovery?', Mental Health and Substance Use, Advance online publication, pp. 1 - 13, http://dx.doi.org/10.1080/17523281.2013.806951
,2013, 'One size fits all? The discursive framing of cultural difference in health professional accounts of providing cancer care to Aboriginal people', Ethnicity and Health, 18, pp. 433 - 447, http://dx.doi.org/10.1080/13557858.2012.754408
,2013, 'Peer education for people who inject drugs in New South Wales: Advantages, unanticipated benefits and challenges', Drugs - Education Prevention and Policy
,2013, 'Under the watchful eye of a ‘benevolent dictator’: General practitioner and patient experiences of hepatitis C treatment initiation', Australian Family Physician, 42, pp. 900 - 903
,2012, 'Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand', International Journal of Integrated Care, 12, http://www.ijic.org/index.php/ijic/article/view/819/1924
,2012, 'Harm minimisation in Australian prisons—health protection still depends on where you serve your time', Medical Journal of Australia, 197, pp. 382 - 382, http://dx.doi.org/10.5694/mja12.10228
,2012, 'Health worker attitudes towards peer workers in hepatitis C prevention', Psychology, Health and Medicine, 17, pp. 659 - 666, http://dx.doi.org/10.1080/13548506.2012.656660
,2012, 'Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs', Drug and Alcohol Review, 31, pp. 918 - 924, http://dx.doi.org/10.1111/j.1465-3362.2012.00468.x
,2012, 'Rethinking safety and fidelity: the role of love and intimacy in hepatitis C transmission and prevention', Health Sociology Review, 21, pp. 272 - 286, http://dx.doi.org/10.5172/hesr.2012.1803
,2012, 'Staying safe from hepatitis C: Engaging with multiple priorities.', Qualitative Health Research, 22, pp. 31 - 42, http://dx.doi.org/10.1177/1049732311420579
,2012, 'Structural constraints on the training of peer educators in hepatitis C prevention', Health Education Research Theory and Practice, 27, pp. 248 - 257, http://dx.doi.org/10.1093/her/cyr094
,2012, 'The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics', Social Science and Medicine, 74, pp. 245 - 253, http://dx.doi.org/10.1016/j.socscimed.2011.10.003
,2011, 'Social inclusion and hepatitis C: Exploring new possibilities for prevention', Expert Review of Anti Infective Therapy, 9, pp. 397 - 404, http://dx.doi.org/10.1586/eri.11.26
,2011, 'Doing things together? Analysis of health education materials to inform hepatitis C prevention among couples', Addiction Research and Theory, 19, pp. 352 - 361, http://dx.doi.org/10.3109/16066359.2011.562619
,2011, 'Evaluation of consumer participation demonstration projects in five australian drug user treatment facilities: The impact of individual versus organizational stability in determining project progress', Substance Use and Misuse, 46, pp. 969 - 979, http://dx.doi.org/10.3109/10826084.2010.540289
,2011, 'Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs', Drug and Alcohol Dependence, 116, pp. 52 - 56, http://dx.doi.org/10.1016/j.drugalcdep.2010.11.018
,2011, 'Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.', Journal of Viral Hepatitis, 18, pp. 104 - 116, http://dx.doi.org/10.1111/j.1365
,2011, 'Hepatitis C, love and intimacy: beyond the 'anomalous body'', Drugs - Education Prevention and Policy, 18, pp. 228 - 236, http://dx.doi.org/10.3109/09687637.2010.485939
,2011, 'Improving surveillance for acute hepatitis C', Communicable Diseases Intelligence Quarterly Report, 35, pp. 16 - 20, http://search.informit.com.au/documentSummary;dn=057496644726691;res=IELHEA
,2011, 'Social inclusion and hepatitis C: exploring new possibilities for prevention', Expert Review of Anti-Infective Therapy, 9, pp. 397 - 404, http://dx.doi.org/10.1586/eri.11.26
,2010, 'PRESENTER 1: OVERVIEW OF TREATMENT OF HEPATITIS C (HCV) IN THE OPIATE PHARMACOTHERAPY SETTING AND THE ENHANCING TREATMENT OF HEPATITIS C IN THE OPIATE SUBSTITUTION SETTING (ETHOS) PARTNERSHIP INITIATIVE', DRUG AND ALCOHOL REVIEW, 29, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'PRESENTER 2: SPECIALIST ASSESSMENT AND TREATMENT OF HEPATITIS C VIRUS INFECTION AMONG INJECTION DRUG USERS IN NEW SOUTH WALES, AUSTRALIA', DRUG AND ALCOHOL REVIEW, 29, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'PRESENTER 3: NUANCING KNOWLEDGE: DEEPENING OUR UNDERSTANDINGS OF DECISIONS ABOUT HEPATITIS C TREATMENT', DRUG AND ALCOHOL REVIEW, 29, pp. 21 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Using mindfulness to develop health education strategies for blood borne virus prevention in injecting drug use', Drugs Education Prevention and Policy, 17, pp. 431 - 442, http://dx.doi.org/10.3109/09687630802585377
,2010, ''Does anyone know where to get fits from around here?' Policy implications for the provision of sterile injecting equipment through pharmacies in Sydney, Australia', Drugs - Education Prevention and Policy, 17, pp. 72 - 83, http://dx.doi.org/10.3109/09687630802067251
,2010, 'A diagnosis of hepatitis C: Insights from a study on patient’s experiences.', Australian Family Physician, 39, pp. 589 - 592, http://www.racgp.org.au/afp/201008/201008treloar.pdf
,2010, 'Assessing community support for harm reduction services: comparing two measures', Drug and Alcohol Review, 29, pp. 385 - 391, http://dx.doi.org/10.1111/j.1465-3362.2009.00151.x
,2010, 'Disclosing hepatitis C infection within everyday contexts: Implications for accessing support and healthcare', Journal of Health Psychology, 15, pp. 811 - 818, http://dx.doi.org/10.1177/1359105310370499
,2010, 'Fitness for duty: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs', Vaccine, 28, pp. 5228 - 5236, http://dx.doi.org/10.1016/j.vaccine.2010.05.064
,2010, 'Hepatitis C in an Australian migrant community: knowledge of and attitudes towards transmission and infection', Contemporary Drug Problems, 37, pp. 659 - 683, http://www.federallegalpublications.com/contemporary-drug-problems/201012/cdp-2010-37-4-contemporary-drug-problems-vol-37-no-4-winter-2010
,